Rabiu Nuhu Danraka

Mr. Rabiu Nuhu Danraka

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 July 2021 in Molecules
Verified
Journal Article
Open access
PDF file
SMSagir Mustapha
Sagir Mustapha
Mustapha MohammedMustapha Mohammed
Mustapha Mohammed
Ahmad Khusairi AzemiAhmad Khusairi Azemi
Ahmad Khusairi Azemi
IAIbrahim Jatau Abubakar
Ibrahim Jatau Abubakar
ASAishatu Shehu
Aishatu Shehu
SMSiti Safiah Mokhtar
Siti Safiah Mokhtar
The endoplasmic reticulum (ER) plays a multifunctional role in lipid biosynthesis, calcium storage, protein folding, and processing. Thus, maintaining ER homeostasis is essential for cellular functions. Several pathophysiological conditions and pharmacological agents are known to disrupt ER homeostasis, thereby, causing ER stress. The cells react to ER stress by initiating an adaptive signaling process called the unfolded protein response (UPR). However, the ER initiates death signaling pathways when ER stress persists. ER stress is linked to several diseases, such as cancer, obesity, and diabetes. Thus, its regulation can provide possible therapeutic targets for these. Current evidence suggests that chronic hyperglycemia and hyperlipidemia linked to type II diabetes disrupt ER homeostasis, thereby, resulting in irreversible UPR activation and cell death. Despite progress in understanding the pathophysiology of the UPR and ER stress, to date, the mechanisms of ER stress in relation to type II diabetes remain unclear. This review provides up-to-date information regarding the UPR, ER stress mechanisms, insulin dysfunction, oxidative stress, and the therapeutic potential of targeting specific ER stress pathways.

1 April 2021 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
MAMubarak Hussaini Ahmad
Mubarak Hussaini Ahmad
AZAbdulkadir Umar Zezi
Abdulkadir Umar Zezi
SASherifat Bola Anafi
Sherifat Bola Anafi
ZAZakariyya Alhassan
Zakariyya Alhassan
Mustapha MohammedMustapha Mohammed
Mustapha Mohammed
RDRabiu Nuhu Danraka
Rabiu Nuhu Danraka

20 January 2024 in AFRICAN JOURNAL OF PHARMACEUTICAL RESEARCH AND DEVELOPMENT
Verified
Journal Article
Closed access
RDRabiu Nuhu Danraka
Rabiu Nuhu Danraka
MSMaryam Adenike Salaudeen
Maryam Adenike Salaudeen
NBNura Bello
Nura Bello
MMMaimunatu Bawa Muhammad
Maimunatu Bawa Muhammad
FKFerhat Khan
Ferhat Khan
MSMuhammad Bashir Sani
Muhammad Bashir Sani

20 January 2024 in AFRICAN JOURNAL OF PHARMACEUTICAL RESEARCH AND DEVELOPMENT
Verified
Journal Article
Closed access
RDRabiu Nuhu Danraka
Rabiu Nuhu Danraka
MSMaryam Adenike Salaudeen
Maryam Adenike Salaudeen
NBNura Bello
Nura Bello
MMMaimunatu Bawa Muhammad
Maimunatu Bawa Muhammad
FKFerhat Khan
Ferhat Khan
MSMuhammad Bashir Sani
Muhammad Bashir Sani

12 September 2024 in AFRICAN JOURNAL OF PHARMACEUTICAL RESEARCH AND DEVELOPMENT
Verified
Journal Article
Closed access
RDRabiu Nuhu Danraka
Rabiu Nuhu Danraka
Hymenodictyon floribundum is a common shrub in Africa that has been used traditionally in the treatment of pain and inflammatory diseases. In this study, the anti-inflammatory activity of the ethanol leaf extract of Hymenodictyon floribundum (EEHF) in rats was studied following phytochemical screening and LD50 determination. The inflammatory activity of EEHF (375, 750 and 1500 mg/kg p.o) was evaluated using carrageenan-induced inflammation model in rats. The preliminary phytochemical screening of the extract revealed the presence of flavonoids, tannins, saponins, steroids glycosides, anthraquinones and phenols. The oral median lethal dose (LD50) of the extract in rats was found to be greater than 5,000 mg/kg body weight. The result of this research revealed the ability of the extract to significantly (p<0.05) reduce paw oedema at the highest used doses, thus supporting the ethnomedicinal claims of the plant for the management of inflammatory conditions.